Shares of Schrodinger, Inc. (NASDAQ:SDGR - Get Free Report) hit a new 52-week high during mid-day trading on Tuesday. The stock traded as high as $33.09 and last traded at $32.60, with a volume of 4612097 shares traded. The stock had previously closed at $30.31.
Wall Street Analysts Forecast Growth
A number of brokerages have weighed in on SDGR. Wall Street Zen upgraded shares of Schrodinger from a "strong sell" rating to a "hold" rating in a research note on Saturday, August 8th. UBS Group assumed coverage on Schrodinger in a research note on Friday, August 14th. They issued a "neutral" rating and a $19.00 price target on the stock. Finally, Weiss Ratings raised Schrodinger from a "sell (e+)" rating to a "sell (d-)" rating in a report on Thursday, August 27th. Three analysts have rated the stock with a Buy rating, two have given a Hold rating and one has assigned a Sell rating to the stock. According to data from MarketBeat, the company presently has a consensus rating of "Hold" and a consensus price target of $20.80.
View Our Latest Research Report on SDGR
Schrodinger Trading Up 7.6%
The stock has a market capitalization of $2.41 billion, a PE ratio of -44.05 and a beta of 1.62. The firm has a 50 day moving average price of $21.76 and a 200 day moving average price of $16.56.
Schrodinger (NASDAQ:SDGR - Get Free Report) last released its earnings results on Wednesday, August 5th. The company reported $0.08 earnings per share for the quarter, beating the consensus estimate of ($0.41) by $0.49. Schrodinger had a negative return on equity of 16.37% and a negative net margin of 20.98%.The company had revenue of $58.89 million for the quarter, compared to the consensus estimate of $47.19 million. During the same period in the previous year, the business earned ($0.65) earnings per share. Schrodinger's quarterly revenue was up 7.5% compared to the same quarter last year. On average, equities research analysts expect that Schrodinger, Inc. will post -1.5 EPS for the current year.
Insider Transactions at Schrodinger
In related news, insider Karen Akinsanya sold 31,599 shares of the stock in a transaction that occurred on Thursday, September 17th. The shares were sold at an average price of $29.37, for a total value of $928,062.63. Following the completion of the sale, the insider directly owned 69,956 shares of the company's stock, valued at approximately $2,054,607.72. This represents a 31.12% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Corporate insiders own 10.10% of the company's stock.
Hedge Funds Weigh In On Schrodinger
A number of hedge funds have recently modified their holdings of the company. BlackRock Inc. purchased a new stake in shares of Schrodinger during the second quarter worth about $170,978,000. Rubric Capital Management LP grew its holdings in Schrodinger by 43.8% during the 1st quarter. Rubric Capital Management LP now owns 6,000,000 shares of the company's stock valued at $68,160,000 after buying an additional 1,828,502 shares in the last quarter. Amova Asset Management Americas Inc. grew its holdings in Schrodinger by 6.8% during the 4th quarter. Amova Asset Management Americas Inc. now owns 2,819,670 shares of the company's stock valued at $50,359,000 after buying an additional 180,735 shares in the last quarter. Bank of New York Mellon Corp bought a new stake in shares of Schrodinger during the second quarter valued at approximately $4,986,000. Finally, Tejara Capital Ltd bought a new stake in shares of Schrodinger during the second quarter valued at approximately $4,553,000. 79.05% of the stock is currently owned by institutional investors.
About Schrodinger
(
Get Free Report)
Schrödinger, Inc is a technology company that develops computational software for pharmaceutical and materials research. Its platform uses physics-based modeling, machine learning and other computational methods to help scientists design and optimize molecules, evaluate potential drug candidates and investigate material properties.
The company's software offerings include molecular modeling, simulation, predictive modeling and collaborative research tools, such as Maestro, Desmond, Jaguar, FEP+ and LiveDesign.
Featured Stories
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Schrodinger, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Schrodinger wasn't on the list.
While Schrodinger currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
The AI boom extends far beyond the biggest tech names. Discover 10 companies supplying the memory, storage, networking, semiconductor manufacturing, and power infrastructure that make AI possible. Learn where the next wave of AI investment opportunities may emerge—and the key risks investors should watch as the global AI buildout accelerates.
Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Like this article? Share it with a colleague.
Link copied to clipboard.